 Home > Biochemistry News > Biotechnology News > Chuangsheng Group announced that its anti-sclerostin monoclonal antibody TST002 was approved for clinical use in China

Chuangsheng Group announced that its anti-sclerostin monoclonal antibody TST002 was approved for clinical use in China

 Last Update: 2021-10-11
 Source: Internet
 Author: User

Tags

benzodiazepines drug class

business process owner

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Suzhou, September 27, 2021/PRNewswire/ - Chuangsheng Group, a clinical-stage biopharmaceutical company with the ability to integrate the entire process of biopharmaceutical discovery, R&D, process development and production, announced today that it is targeting severe osteoporosis The anti-sclerostin monoclonal antibody TST002 was officially approved by the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) on September 22.

At present, more than 100 million people in China suffer from osteoporosis of varying degrees, and 4 million of them suffer from severe osteoporosis.

TST002 (Blosozumab) is a humanized anti-sclerostin monoclonal antibody drug candidate for severe osteoporosis.

TST002 (Blosozumab) is the earliest research and development by Eli Lilly and has completed Phase II clinical studies in the United States and Japan

"As the population ageing trend intensifies, osteoporosis is bringing a heavier disease burden to the Chinese medical system

About Chuangsheng Group

Chuangsheng Group is a clinical stage biopharmaceutical company with comprehensive capabilities in biopharmaceutical discovery, research and development, process development and production

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.